Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • COMMON SEASONAL CORONAVIRUSES DOESN’T OFFER ANY PROTECTION-FIND OUT!

Engineered antibody: Potential cure to COVID – 19?

Chapare virus: A new Arenavirus threat to mankind

COMMON SEASONAL CORONAVIRUSES DOESN’T OFFER ANY PROTECTION-FIND OUT!
  • BiotechToday
  • World

COMMON SEASONAL CORONAVIRUSES DOESN’T OFFER ANY PROTECTION-FIND OUT!

bioxone November 22, 2020November 22, 2020

AISHILA KAR, AMITY UNIVERSITY KOLKATA

Severe respiratory problem coronavirus 2 (SARS-CoV-2) has fastly spread within the human population. In spite of the fact, SARS-CoV-2 is a novel coronavirus, most humans had been early exposed to other antigenically different common seasonal human coronaviruses (hCoVs) earlier than the COVID-19 pandemic. Few scientists have suggested that people might be protected from SARS-CoV-2 infection if they have lately been caught by a seasonal coronavirus.

In Philadelphia, Scott Hensley at the University of Pennsylvania and his colleagues examined blood samples recovered before the pandemic from around 500 people. After that, they longitudinally measured hCoV and SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients. Their studies indicate that most people already gave hCoV-reactive antibodies before the COVID-19 pandemic. They found that ∼23% of these people already have antibodies that could recognize SARS-CoV-2, which apparently developed in response to infection with a common-cold coronavirus.

Half of the people apparently catch SARS-CoV-2. People who became infected by this and those who didn’t had same level of antibodies recognizing SARS-CoV-2. This suggests that neither those antibodies nor those that recognize OC43 offer any protection against infection.

Also read: Engineered antibody: Potential cure to COVID – 19?

SOURCE- https://www.nature.com/articles/d41586-020-00502-w

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibody blood sample CORONAVIRUS patients Philadelphia SARS-CoV-2 seasonal coronavirus serum virus infection

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Chapare virus: A new Arenavirus threat to mankind

bioxone November 23, 2020

Sayak Banerjee, Amity University Kolkata According to the American Society of Tropical Medicine and Hygiene (ASTMH), The US Centers for Disease Control and Prevention (CDC) discovered a deadly virus, named Chapare virus that caused more than five infections near Bolivia’s capital city, La Paz, out of which three are fatal.  The researchers attested that the […]

Chapare virus

Related Post

  • BiotechToday
  • World

Plasmodium immunotherapy against Cancer

BioTech Today July 16, 2021July 16, 2021

Aqsa, Jamia Millia Islamia Cancer is a disease in which cells of the body grow abnormally and uncontrollably. Until now, there is still no permanent cure for cancer, but getting treatment for cancer might allow you to live for a certain period. Research for the cure of cancer has been underway for about 100 years […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Nanoworms used to inactivate and kill COVID-19 germs

BioTech Today September 29, 2021September 29, 2021

Ananya Ghosal, MAKAUT(WB) The increasing rate of the variants of Coronavirus resulting in an outpouring of diseases in the whole world. The mutation occurring in the spike protein of the virion raise the question of vaccine effectiveness and allows greater transmission. Effective inactivation of the virus is required to prevent the spread of SARS-CoV-2 and […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Mynvax raises $4.2M to develop ‘thermostable’ Covid-vaccine

bioxone July 22, 2021July 22, 2021

Monika Raman, PSG College of Technology, Coimbatore By introducing new mutants, SARS-CoV-2 brings a new global threat with every new day. This current pandemic situation is a race between implementing vaccinations and controlling newly emerging infectious variants of coronavirus.  To fight this situation, the Indian Institute of Science (IISc) in Bengaluru has successfully developed a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy